Late Breaking Abstract - Switching from PDE5i to riociguat in patients with PAH: The REPLACE study

M. Hoeper (Hannover, Germany), H. Ghofrani (Giessen, Germany), H. Al-Hiti (Prague, Czech Republic), R. Benza (Columbus, OH, United States of America), S. Chang (Seoul, Republic of Korea), P. Corris (Newcastle upon Tyne, United Kingdom), S. Gibbs (London, United Kingdom), E. Grünig (Heidelberg, Germany), P. Jansa (Prague, Czech Republic), J. Klinger (Providence, RI, United States of America), D. Langleben (Montreal, QC, Canada), V. Mclaughlin (Ann Arbor, MI, United States of America), G. Meyer (Porto Alegre, Brazil), J. Ota-Arakaki (São Paulo, Brazil), A. Peacock (Glasgow, United Kingdom), T. Pulido (Mexico City, Mexico), S. Rosenkranz (Cologne, Germany), D. Vizza (Rome, Italy), A. Vonk-Noordegraaf (Amsterdam, Netherlands), J. White (Rochester, NY, United States of America), M. Chang (Berlin, Germany), F. Kleinjung (Berlin, Germany), C. Meier (Berlin, Germany), K. Paraschin (São Paulo, Brazil), G. Simonneau (Le Kremlin-Bicêtre, France)

Source: Virtual Congress 2020 – ALERT: Pneumothorax, cough, PAH, alveolar proteinosis
Session: ALERT: Pneumothorax, cough, PAH, alveolar proteinosis
Session type: Clinical trials session
Number: 3802

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Hoeper (Hannover, Germany), H. Ghofrani (Giessen, Germany), H. Al-Hiti (Prague, Czech Republic), R. Benza (Columbus, OH, United States of America), S. Chang (Seoul, Republic of Korea), P. Corris (Newcastle upon Tyne, United Kingdom), S. Gibbs (London, United Kingdom), E. Grünig (Heidelberg, Germany), P. Jansa (Prague, Czech Republic), J. Klinger (Providence, RI, United States of America), D. Langleben (Montreal, QC, Canada), V. Mclaughlin (Ann Arbor, MI, United States of America), G. Meyer (Porto Alegre, Brazil), J. Ota-Arakaki (São Paulo, Brazil), A. Peacock (Glasgow, United Kingdom), T. Pulido (Mexico City, Mexico), S. Rosenkranz (Cologne, Germany), D. Vizza (Rome, Italy), A. Vonk-Noordegraaf (Amsterdam, Netherlands), J. White (Rochester, NY, United States of America), M. Chang (Berlin, Germany), F. Kleinjung (Berlin, Germany), C. Meier (Berlin, Germany), K. Paraschin (São Paulo, Brazil), G. Simonneau (Le Kremlin-Bicêtre, France). Late Breaking Abstract - Switching from PDE5i to riociguat in patients with PAH: The REPLACE study. 3802

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: